Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Cardioprotection by systemic dosing of thymosin beta four following ischemic myocardial injury.

Bao W, Ballard VL, Needle S, Hoang B, Lenhard SC, Tunstead JR, Jucker BM, Willette RN, Pipes GT.

Front Pharmacol. 2013 Nov 29;4:149. doi: 10.3389/fphar.2013.00149. eCollection 2013.

2.

Cardioprotection by Thymosin Beta 4.

Pipes GT, Yang J.

Vitam Horm. 2016;102:209-26. doi: 10.1016/bs.vh.2016.04.004. Epub 2016 May 31. Review.

PMID:
27450736
3.

Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection.

Hinkel R, El-Aouni C, Olson T, Horstkotte J, Mayer S, Müller S, Willhauck M, Spitzweg C, Gildehaus FJ, Münzing W, Hannappel E, Bock-Marquette I, DiMaio JM, Hatzopoulos AK, Boekstegers P, Kupatt C.

Circulation. 2008 Apr 29;117(17):2232-40. doi: 10.1161/CIRCULATIONAHA.107.758904. Epub 2008 Apr 21.

4.

Thymosin-β4 prevents cardiac rupture and improves cardiac function in mice with myocardial infarction.

Peng H, Xu J, Yang XP, Dai X, Peterson EL, Carretero OA, Rhaleb NE.

Am J Physiol Heart Circ Physiol. 2014 Sep 1;307(5):H741-51. doi: 10.1152/ajpheart.00129.2014. Epub 2014 Jul 11.

5.

Thymosin β4 increases the potency of transplanted mesenchymal stem cells for myocardial repair.

Ye L, Zhang P, Duval S, Su L, Xiong Q, Zhang J.

Circulation. 2013 Sep 10;128(11 Suppl 1):S32-41. doi: 10.1161/CIRCULATIONAHA.112.000025.

6.

Application of peripheral-blood-derived endothelial progenitor cell for treating ischemia-reperfusion injury and infarction: a preclinical study in rat models.

Chang ZT, Hong L, Wang H, Lai HL, Li LF, Yin QL.

J Cardiothorac Surg. 2013 Mar 1;8:33. doi: 10.1186/1749-8090-8-33.

7.

Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles.

Huang Z, Song Y, Pang Z, Zhang B, Yang H, Shi H, Chen J, Gong H, Qian J, Ge J.

Int J Nanomedicine. 2017 Apr 12;12:3023-3036. doi: 10.2147/IJN.S131949. eCollection 2017.

8.
9.

The reduction of infarct size--forty years of research.

Ferreira R.

Rev Port Cardiol. 2010 Jun;29(6):1037-53. Review. English, Portuguese.

10.
11.

Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.

Morris DC, Chopp M, Zhang L, Lu M, Zhang ZG.

Neuroscience. 2010 Aug 25;169(2):674-82. doi: 10.1016/j.neuroscience.2010.05.017.

12.

Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.

Bao W, Holt LJ, Prince RD, Jones GX, Aravindhan K, Szapacs M, Barbour AM, Jolivette LJ, Lepore JJ, Willette RN, DeAngelis E, Jucker BM.

Cardiovasc Diabetol. 2013 Oct 14;12:148. doi: 10.1186/1475-2840-12-148.

13.

Thymosin β4 promotes the survival and angiogenesis of transplanted endothelial progenitor cells in the infarcted myocardium.

Quan Z, Wang QL, Zhou P, Wang GD, Tan YZ, Wang HJ.

Int J Mol Med. 2017 Jun;39(6):1347-1356. doi: 10.3892/ijmm.2017.2950. Epub 2017 Apr 11.

14.

Beneficial effects of thymosin β4 on spinal cord injury in the rat.

Cheng P, Kuang F, Zhang H, Ju G, Wang J.

Neuropharmacology. 2014 Oct;85:408-16. doi: 10.1016/j.neuropharm.2014.06.004. Epub 2014 Jun 14.

PMID:
24937047
15.

MiR-200a mediates protection of thymosin beta 4 in cardiac microvascular endothelial cells as a novel mechanism under hypoxia-reoxygenation injury.

Li Y, Zhu X, Liu X, Du A, Yu B.

J Cell Biochem. 2017 Aug 31. doi: 10.1002/jcb.26381. [Epub ahead of print]

PMID:
28857257
16.

Molecular and cellular mechanisms of thymosin β4-mediated cardioprotection.

Hinkel R, Trenkwalder T, Kupatt C.

Ann N Y Acad Sci. 2012 Oct;1269:102-9. doi: 10.1111/j.1749-6632.2012.06693.x.

PMID:
23045977
17.

Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion.

Jiang ZS, Srisakuldee W, Soulet F, Bouche G, Kardami E.

Cardiovasc Res. 2004 Apr 1;62(1):154-66.

PMID:
15023562
18.

Development of thymosin beta4 for treatment of patients with ischemic heart disease.

Crockford D.

Ann N Y Acad Sci. 2007 Sep;1112:385-95.

PMID:
17947592
19.

Thymosin beta 4 protects cardiomyocytes from oxidative stress by targeting anti-oxidative enzymes and anti-apoptotic genes.

Wei C, Kumar S, Kim IK, Gupta S.

PLoS One. 2012;7(8):e42586. doi: 10.1371/journal.pone.0042586. Epub 2012 Aug 3.

20.

Increases in plasma Tβ4 after intracardiac cell therapy in chronic ischemic heart failure is associated with symptomatic improvement.

Choudry FA, Yeo C, Mozid A, Martin JF, Mathur A.

Regen Med. 2015 May;10(4):403-10. doi: 10.2217/rme.15.9.

PMID:
26022762

Supplemental Content

Support Center